Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Chian-Pei Li"'
Autor:
Ying-Ju Chen, Ying-Hsuan Wang, Yi-Hua Lai, Ming-Chung Wang, Cih-En Huang, Yi-Yang Chen, Yu-Ying Wu, Yao-Ren Yang, Hsing-Yi Tsou, Chian-Pei LI, Chia-Chen Hsu, Chih-Cheng Chen
Publikováno v:
HemaSphere, Vol 7, p e36709f8 (2023)
Externí odkaz:
https://doaj.org/article/95704c575bab4f73b0e8349d3d09efe3
Autor:
Cih-En Huang, Wei-Ming Chen, Yu-Ying Wu, Chien-Heng Shen, Chia-Chen Hsu, Chian-Pei Li, Min-Chi Chen, Jung-Jung Chang, Yi-Yang Chen, Chang-Hsien Lu, Chung-Sheng Shi, Chih-Cheng Chen
Publikováno v:
Platelets, Vol 32, Iss 8, Pp 1043-1050 (2021)
Hepatitis C virus-associated immune thrombocytopenia (HCV-ITP) has been assumed to be one of secondary ITP and associated with antiplatelet antibodies. This study was to clarify the antibody profile in HCV-ITP compared with primary ITP. We enrolled 5
Externí odkaz:
https://doaj.org/article/fa44194f0190420a8db2f88f62189603
Autor:
Chia-Chen Hsu, Cih-En Huang, Yu-Ying Wu, Yi-Yang Chen, Jrhau Lung, Yu-Wei Leu, Chian-Pei Li, Hsing-Yi Tsou, Wei-Hsuan Chuang, Chang-Hsien Lu, Chih-Cheng Chen
Publikováno v:
Haematologica, Vol 103, Iss 10 (2018)
Externí odkaz:
https://doaj.org/article/93a30936c8c84efca870adfb18b7060d
Autor:
Chih-Cheng Chen, Jie-Yu You, Jrhau Lung, Cih-En Huang, Yi-Yang Chen, Yu-Wei Leu, Hsing-Ying Ho, Chian-Pei Li, Chang-Hsien Lu, Kuan-Der Lee, Chia-Chen Hsu, Jyh-Pyng Gau
Publikováno v:
Haematologica, Vol 102, Iss 3 (2017)
High mobility group AT-hook 2 (HMGA2) is an architectural transcription factor that is negatively regulated by let-7 microRNA through binding to it’s 3′-untranslated region. Transgenic mice expressing Hmga2 with a truncation of its 3′-untransla
Externí odkaz:
https://doaj.org/article/e40999f54822491eaf83c7148547c88f
Autor:
Chian-Pei Li, 李芊霈
102
Monascus species used in East Asian countries to enhance food color and medicine effency. Many studies demonstrated that red mold rice can prevent cardiovascular disease, but the regulation mechanism of red mold rice in cardiac hypertrophy i
Monascus species used in East Asian countries to enhance food color and medicine effency. Many studies demonstrated that red mold rice can prevent cardiovascular disease, but the regulation mechanism of red mold rice in cardiac hypertrophy i
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/6xxpgs
Autor:
Chia-Chen Hsu, Ying-Hsuan Wang, Yi-Yang Chen, Ying-Ju Chen, Chang-Hsien Lu, Yu-Ying Wu, Yao-Ren Yang, Hsing-Yi Tsou, Chian-Pei Li, Cih-En Huang, Chih-Cheng Chen
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3435
Patients with myeloproliferative neoplasms (MPNs) are characterized by systemic inflammation. With the indolent nature of the diseases, second cancers (SCs) have emerged as a challenging issue in afflicted patients. Epidemiological studies have confi
Autor:
Ying-Hsuan Wang, Ying-Ju Chen, Yi-Hua Lai, Ming-Chung Wang, Yi-Yang Chen, Yu-Ying Wu, Yao-Ren Yang, Hsing-Yi Tsou, Chian-Pei Li, Chia-Chen Hsu, Cih-En Huang, Chih-Cheng Chen
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 10; Pages: 8747
Numerous pathogenic CALR exon 9 mutations have been identified in myeloproliferative neoplasms (MPN), with type 1 (52bp deletion; CALRDEL) and type 2 (5bp insertion; CALRINS) being the most prevalent. Despite the universal pathobiology of MPN driven
Autor:
Wei-Ming Chen, Yi-Yang Chen, Yu-Ying Wu, Jung-Jung Chang, Chih-Cheng Chen, Cih-En Huang, Chian-Pei Li, Chien-Heng Shen, Chia-Chen Hsu, Chung-Sheng Shi, Chang-Hsien Lu, Min-Chi Chen
Publikováno v:
Platelets. 32(8)
Hepatitis C virus-associated immune thrombocytopenia (HCV-ITP) has been assumed to be one of secondary ITP and associated with antiplatelet antibodies. This study was to clarify the antibody profile in HCV-ITP compared with primary ITP. We enrolled 5
Autor:
Chia-Chen Hsu, Chian-Pei Li, Yu-Ying Wu, Ying-Ju Chen, Chang-Hsien Lu, Cih-En Huang, Chih-Cheng Chen, Ping-Tsung Chen, Yi-Hua Lai, Hsing-Yi Tsou
Publikováno v:
Journal of the Formosan Medical Association = Taiwan yi zhi. 120(2)
Background/purpose Ropeginterferon alpha-2b (Ropeg) is a novel pegylated interferon-alpha recently approved for the treatment of polycythemia vera (PV) in Europe. However, other than data from clinical trials, little is known about this agent in real
Autor:
Chih-Cheng Chen, Cih-En Huang, Chian-Pei Li, Chang-Hsien Lu, Chia-Chen Hsu, Jie-Yu You, Hsing-Yi Tsou, Ping-Tsung Chen, Yi-Yang Chen, Yu-Ying Wu, Ying-Ju Chen, Yi-Hua Lai
Publikováno v:
Translational Cancer Research
Background Aberrant MYC and BCL2 expression, cell of origin (COO), and National Comprehensive Cancer Network international prognostic index (NCCN-IPI) are commonly used for risk assessment and treatment decision in patients with diffuse large B-cell